IBSA Pharma
The computed 12-month bankruptcy probability of IBSA Pharma is 2.9% (moderate). The 2025 annual accounts show equity of €35k and a net result of €1k. Its solvency ranks better than 59% of 179 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €35k |
| Net result | €1k |
| Staff (FTE) | 2 |
| Better than sector | 59% |
Strong profile, led by stability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 48.6% | 42.8% | |
| Net result | €1k | €186k | |
| Equity | €35k | €1.19M | |
| Gross operating margin | €253k | €184k | |
| Staff costs | €233k | €777k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €1k |
| Cash flow | - |
| Staff costs | €233k |
| Income taxes | €11k |
| Dividends | - |
| Total assets | €72k |
| Equity | €35k |
| Debt | €37k |
| of which ≤ 1y | €37k |
| of which > 1y | - |
| Working capital | €35k |
| Employees (FTE) | 2.0 |
| 2025 | |
|---|---|
| Current ratio | 1.95 |
| Quick ratio | 1.95 |
| Working capital ratio | 48.6% |
| Solvency | 48.6% |
| Debt / equity | 1.06 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 1.8% |
| ROE | 3.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €72k |
| Current assets | 29/58 | €72k |
| Amounts receivable within one year | 40/41 | €50k |
| Cash & bank | 54/58 | €21k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €72k |
| Equity | 10/15 | €35k |
| Contributions / capital | 10/11 | €25k |
| Accumulated profits (losses) | 14 | €10k |
| Amounts payable | 17/49 | €37k |
| Amounts payable within one year | 42/48 | €37k |
| Trade debts payable within one year | 44 | €6k |
| Income statement | ||
| Gross operating margin | 9900 | €253k |
| Operating result | 9901 | €19k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €7k |
| Result before taxes | 9903 | €12k |
| Income taxes | 67/77 | €11k |
| Net result for the period | 9904 | €1k |
| Result to be appropriated | 9905 | €1k |
-
Current13-07-2023 → present
| NACE primary | Wholesale trade(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 22-12-2022 |
| Status | Active |
| Postal code | 1000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21805E0463/00W002 | Brussels | 1,034 m² | 1 · 895 m² | 32.6 m · 8 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
26-05-2026 Officer resignation · Officer appointment · Power of attorney · Act object
- Filing: 2026-05-18 · IBSA PHARMA
- Publication: 2026-05-26 · IBSA PHARMA
- Officer resignation: date: 2025-09-30 · Melli Antonio
- Officer appointment: date: 2025-04-15, duration: indéterminée, compensation: non rémunéré · Arturo-Pino Giuseppe Antonio LICENZIATI
- Power of attorney: scope: signer tout document et d'accomplir toute formalité nécessaire en vue de la publication des décisions mentionnées ci-dessus dans les Annexes du Moniteur belge, acting: séparément · IBSA PHARMA
- Act object: Démission/Nomination d'un administrateur
Technical details
{
"facts": [
{
"type": "filing",
"quote": "D\u00E9pos\u00E9 /Re\u00E7u le 18 MAI 2026",
"value": "2026-05-18",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 26/05/2026 - Annexes du Moniteur belge",
"value": "2026-05-26",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire prend connaissance de la fin du mandat au 30/09/2025 de l\u0027administrateur Monsieur Melli Antonio",
"value": {
"date": "2025-09-30"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_appointment",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire d\u00E9cide de d\u00E9signer comme nouvel administrateur: Arturo-Pino Giuseppe Antonio LICENZIATI. Son mandat prendra effet le 15/04/2025 et aura une dur\u00E9e ind\u00E9termin\u00E9e. Le mandat de l\u0027administrateur ne sera pas r\u00E9mun\u00E9r\u00E9, sauf d\u00E9cision contraire de l\u0027assembl\u00E9e g\u00E9n\u00E9rale.",
"value": {
"date": "2025-04-15",
"duration": "ind\u00E9termin\u00E9e",
"compensation": "non r\u00E9mun\u00E9r\u00E9"
},
"object": "e1",
"subject": "e3"
},
{
"type": "power_of_attorney",
"quote": "DECIDE de donner tous pouvoirs \u00E0 Monsieur Lengel\u00E9 Nicolas, collaborateurs au sein de BDO Experts-Comptables \u0026 Conseillers Fiscaux, dont le si\u00E8ge social est \u00E9tabli Da Vincilaan, 9 E.6 \u00E0 1930 Zaventem, immatricul\u00E9e \u00E0 la Banque-Carrefour des Entreprises sous le num\u00E9ro 0438.475.137 (RPM Bruxelles, tribunaux n\u00E9erlandophones), agissant s\u00E9par\u00E9ment, avec pouvoir de substitution, aux fins de signer tout document et d\u0027accomplir toute formalit\u00E9 n\u00E9cessaire en vue de la publication des d\u00E9cisions mentionn\u00E9es ci-dessus dans les Annexes du Moniteur belge.",
"value": {
"scope": "signer tout document et d\u0027accomplir toute formalit\u00E9 n\u00E9cessaire en vue de la publication des d\u00E9cisions mentionn\u00E9es ci-dessus dans les Annexes du Moniteur belge",
"acting": "s\u00E9par\u00E9ment",
"substitution": true
},
"object": "e4",
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: D\u00E9mission/Nomination d\u0027un administrateur",
"value": "D\u00E9mission/Nomination d\u0027un administrateur",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 2087,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0795.266.574",
"kind": "company",
"name": "IBSA PHARMA",
"attrs": {
"seat": "Square de Mee\u00FBs 37,1000 Bruxelles",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Melli Antonio",
"attrs": {
"role": "administrateur"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Arturo-Pino Giuseppe Antonio LICENZIATI",
"attrs": {
"role": "administrateur"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Lengel\u00E9 Nicolas",
"attrs": {
"role": "collaborateurs au sein de BDO Experts-Comptables \u0026 Conseillers Fiscaux"
}
},
{
"id": "e5",
"kbo": "0438.475.137",
"kind": "org",
"name": "BDO Experts-Comptables \u0026 Conseillers Fiscaux",
"attrs": {
"seat": "Da Vincilaan, 9 E.6 \u00E0 1930 Zaventem"
}
}
]
}24-08-2023 Elisabetta Racca appointed as director
- Elisabetta Racca, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Elisabetta Racca",
"address": null,
"birth_date": null
},
"effective_date": "2023-07-13",
"evidence_quote": "L\u0027actionnaire unique d\u00E9cide de nommer Mrs. Elisabetta Racca, r\u00E9sidant \u00E0 Via Per Arogno 17, 22061 Campione D\u0027italia (CO), Italie, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet \u00E0 la date des pr\u00E9sentes r\u00E9solutions"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0795.266.574",
"name_full": "IBSA PHARMA",
"legal_form": "SRL"
}
}27-12-2022 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1000 Bruxelles, Square de Mee\u00FBs 37",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": null,
"name": "IBSA Holding SA"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "nominatives",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "IBSA Holding SA",
"contribution_type": "cash",
"amount_paid_in_eur": 25000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 25000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 25000,
"subject_company": {
"kbo": "0795.266.574",
"name_full": "IBSA Pharma",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2022-12-21",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | IBSA Pharma |